Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection
Wulfran Cacheux, Étienne Rouleau, Adrien Briaux, et al.
British Journal of Cancer (2016) Vol. 114, Iss. 12, pp. 1387-1394
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics Advances
Soledad Iseas, Golubicki Mariano, Louis Gros, et al.
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 2, pp. 201-214
Open Access | Times Cited: 7
Biomarkers in anal cancer: from biological understanding to stratified treatment
Christopher M. Jones, Vicky Goh, David Sebag‐Montefiore, et al.
British Journal of Cancer (2016) Vol. 116, Iss. 2, pp. 156-162
Open Access | Times Cited: 54
Clinical relevance and implications of HPV-induced neoplasia in different anatomical locations
Elena Sophie Prigge, Magnus von Knebel Doeberitz, Miriam Reuschenbach
Mutation Research/Reviews in Mutation Research (2016) Vol. 772, pp. 51-66
Closed Access | Times Cited: 47
Prognostic Significance of HPV DNA and p16INK4a in Anal Cancer: A Systematic Review and Meta-Analysis
Aivara Urbutė, Christina Louise Rasmussen, F. Belmonte, et al.
Cancer Epidemiology Biomarkers & Prevention (2020) Vol. 29, Iss. 4, pp. 703-710
Closed Access | Times Cited: 36
Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status
Xiaoqin Zhu, Sarah Jamshed, Jian Zou, et al.
Modern Pathology (2021) Vol. 34, Iss. 5, pp. 1017-1030
Open Access | Times Cited: 31
Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma
Juliette Mainguené, Sophie Vacher, Maud Kamal, et al.
Molecular Oncology (2022) Vol. 16, Iss. 16, pp. 3001-3016
Open Access | Times Cited: 21
Mechanistic Signatures of Human Papillomavirus Insertions in Anal Squamous Cell Carcinomas
Adeline Morel, Cindy Neuzillet, Maxime Wack, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1846-1846
Open Access | Times Cited: 30
Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma
Daniel Martin, Franz Rödel, Stephanie Hehlgans, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Biological features of squamous cell carcinoma of the anus—a deep dive review
Robert Samuel, N. Winder, Morten Busk, et al.
ESMO Gastrointestinal Oncology (2025), pp. 100157-100157
Open Access
HPV circulating tumor DNA to monitor the efficacy of anti‐PD‐1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report
Luc Cabel, François‐Clément Bidard, Vincent Servois, et al.
International Journal of Cancer (2017) Vol. 141, Iss. 8, pp. 1667-1670
Open Access | Times Cited: 30
Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma
Wulfran Cacheux, Virginie Dangles-Marie, Étienne Rouleau, et al.
Oncotarget (2017) Vol. 9, Iss. 1, pp. 464-476
Open Access | Times Cited: 30
Two distinct pathogenic pathways of digital papillary adenocarcinoma — BRAF mutation or low‐risk HPV infection
Chau M. Bui, Tatsiana Pukhalskaya, Bruce R. Smoller, et al.
Journal of Cutaneous Pathology (2023) Vol. 50, Iss. 6, pp. 568-576
Closed Access | Times Cited: 9
Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer
Franz Rödel, Maximilian Fleischmann, Markus Diefenhardt, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access
Activating Mutations in Pik3ca Contribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 Oncogenes
Myeong-Kyun Shin, Susan Payne, Andrea Bilger, et al.
Clinical Cancer Research (2018) Vol. 25, Iss. 6, pp. 1889-1900
Open Access | Times Cited: 27
The Management and Prevention of Anal Squamous Cell Carcinoma
Cathy Eng, Craig Messick, R. Glynne‐Jones
American Society of Clinical Oncology Educational Book (2019), Iss. 39, pp. 216-225
Closed Access | Times Cited: 23
p120-Catenin Downregulation and PIK3CA Mutations Cooperate to Induce Invasion through MMP1 in HNSCC
Michal Kidacki, Heather L. Lehman, Michelle V. Green, et al.
Molecular Cancer Research (2017) Vol. 15, Iss. 10, pp. 1398-1409
Open Access | Times Cited: 22
Genomic Landscape of Primary and Recurrent Anal Squamous Cell Carcinomas in Relation to HPV Integration, Copy-Number Variation, and DNA Damage Response Genes
Jordan Aldersley, David R. Lorenz, Kent W. Mouw, et al.
Molecular Cancer Research (2021) Vol. 19, Iss. 8, pp. 1308-1321
Open Access | Times Cited: 17
Interaction between IGF2‐PI3K axis and cancer‐associated‐fibroblasts promotes anal squamous carcinogenesis
Wulfran Cacheux, Astrid Lièvre, Sophie Richon, et al.
International Journal of Cancer (2019) Vol. 145, Iss. 7, pp. 1852-1859
Open Access | Times Cited: 19
Molecular characterization of squamous cell carcinoma of the anal canal
Samantha Armstrong, Rita Malley, Hongkun Wang, et al.
Journal of Gastrointestinal Oncology (2021) Vol. 12, Iss. 5, pp. 2423-2437
Open Access | Times Cited: 16
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection
Abderaouf Hamza, Julien Masliah‐Planchon, Cindy Neuzillet, et al.
International Journal of Cancer (2023) Vol. 154, Iss. 3, pp. 504-515
Open Access | Times Cited: 6
Oncologic Outcomes of Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma Initially Managed with Chemoradiation
Roni Rosen, Felipe Quezada-Díaz, Mithat Gönen, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2156-2156
Open Access | Times Cited: 2
The first comprehensive genomic characterization of rectal squamous cell carcinoma
Christoforos Astaras, Claudio De Vito, Prasad Chaskar, et al.
Journal of Gastroenterology (2022) Vol. 58, Iss. 2, pp. 125-134
Open Access | Times Cited: 10
Prognostic Value of Fusobacterium nucleatum after Abdominoperineal Resection for Anal Squamous Cell Carcinoma
Marc Hilmi, Cindy Neuzillet, Jérémie H. Lefèvre, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1606-1606
Open Access | Times Cited: 9
NPRA promotes fatty acid metabolism and proliferation of gastric cancer cells by binding to PPARα
Tingting Cao, Song Wang, Long Qian, et al.
Translational Oncology (2023) Vol. 35, pp. 101734-101734
Open Access | Times Cited: 5
Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrences
Wulfran Cacheux, Petros Tsantoulis, Adrien Briaux, et al.
Cancer Medicine (2018) Vol. 7, Iss. 7, pp. 3213-3225
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top